Tetracycline 10mg/g ointment eye

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

tetracycline

Available from:

Tatchempharmpreparaty JSC

ATC code:

S01AA09

INN (International Name):

tetracycline

Dosage:

10mg/g

Pharmaceutical form:

ointment eye

Units in package:

aluminium tube 3g, aluminium tube 10g

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2015-07-03

Summary of Product characteristics

1 .
O6qas
xapaxTepr{crrrra
JreKapcrBa
Hasnauue
JrenapcrBff
Terpaquxluu
Konsqectnennrrfi
u Ka.recrBensnrft
cocraB:
Arcmue
uarc
uu
zp
e
d
u
eumat
:
TerpaqllrnaH
(n
nepec'rdre
na
100
% neuecrso)
B
cnouozamefi
bHbr
e uu
apeduerumut
:
Jlasorus
6esno4nru?
Ba-:elus
7
- 1 , 0 r
-
40,0
r
-
to
100,0
r
3 .
4 .
Jlenapcrnennan
{ropma
Masr
rnasga"a
Onucanue
Masr
or
xeJrroBaroro
Ao
xeJIToBaro-KopI4rIHeBoro
IIBera.
tDapnrarcorepaneBTuqecKarr
rpynna
Anrul6uoruK-Terpar{r{KJlfi
H.
itosATX:
[S01AA09]
Krunr.rq
eucue
xap
anTeprr
crrrKrr
7.
L TepauenTr.rsecrue
nortrlanr{t
Earcrepua,nrnue
(n
r.rl.
xraMl{gnfinue)
uHfexuun
ura3, B6r3BaHHbre
qyncrBrrrerbuhrMr{
K
rerpaqlrKJlr[Hy
MHKpoopraHH3MaMH
-
6re$apnr,
6ne$apoxon6rouror.rBr4T,
Keparr{rr
KeparoKoHbIoHKTr{Br{T,
uefi 6oiraur
(x.menr),
TpaxoMa.
7.2.
Cnocodbr
trpuMeneHr{s
H
Ao3br
{i}ftlti"Ytlt}
J$*
Mecruo.
6 .
1
flonocry
Ma3rr
or 0,5
,qo
I
cu
:axna4LrBaror
3a
BeKo:
ir';'rffi{b
'r"#
'""rJt''A'b:J!'*
flZ''
-
npu
6ne$apnre,
6ne$apoKoHbrouKrr{
snre:
3
-4p*u
u
t.riij
"
tltffi
.
----
-Apiii#irr.:::-.*:*L^*r4*t*
.
i,
+
-
npl4
lrcparr{re,
KeparoKolrbroHKrn
snre:
2-3
pa3a
B
AeHl
B'*t'e.re
Hfic"s"T
tffi.e{.
ffi".J**!."rn.
3-5
Rneft
cocrorur.re
He
ynrrmaercfi,
cJreAyer
npoKor{cyJrbrr,rpoBarbc.r
c BpaqoM;
-
npu
naefiOotrllare
(r'ruenr):
Ha
HoqL
Ao
ucqe3uoBenr{.rr
cr4M[ToNroB
BocrraJrerrr{fi;
-
npll
TpaxoMe:
KalK.4bIe
2'4
q
pIJIIT
qarrl€
B
Teqegr4e
l-2
r{eAerr-6.
flpra
crrrxannr{
BoclrarlrTerbHoro
npoqecca
npelrapar
npl{Merurror
2-3
paza
B
AeHb.
,{nnrelnnocrb
Kypca
neqeur4fi
TpaxoMhr
1-2
naecxqa.
7.
3 . flporrarofi
or€3aurrt
fi'lnep'ryrcrBl'rreJlbl{ocrb,
Hapy[reHue
{rynnqus
neqeuu
}r rroqeK,
6epeiueunocrb,
KopMJreH-ae
fpyAbro,
gercrufi
Bospacr
(no
B
ner).
f!
I
_*-*7r""
7,4.
Cnetryanbrlble
npe,uocrepelKeHnfi
Ia
oco6ue
Mepbr
npe,4ocropoxlrocrl'I
Ilaquegmrrr,
y
KOTOpbrx
frocJre
afirrlrlrKallllE
BpeMeHHO
TepfieTcfl
TIeTKOCTb
3pel{I{fi,
I{e
peKoMegAyercfl
BoAHTb
Mililrlruy
unu
pa6orarb co cJloxcrofi
texsulcofi,
ctanKailtu
rLltr[
KaKllM-
ma6o
ApyraM
cJlolKuhrl,,t
o6opy,Uonanuerrn,
rpedyrorqrau
qeTKocTlI
3